Belgium· BE-AMP-SAM661596-00
Deanxit 10 mg - 0.5 mg
A melitracen und psycholeptika product containing melitracen hydrochloride, registered in Belgium by PI Pharma. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Melitracen und psycholeptika is registered in 3 of 19 countries.
Countries holding a registration under ATC N06CA02 (melitracen und psycholeptika), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Melitracen und psycholeptika · ATC N06CA02
3 / 19 countries
- Belgiumprice
- Norwayprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Melitracen Hydrochloride
- Manufacturer
- PI Pharma
- Country
- Belgium (BE)
- ATC code
- N06CA02
- ATC class
- Melitracen und Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4744637
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for melitracen und psycholeptika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Melitracen und psycholeptika · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06CA02
Melitracen und psycholeptika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a1263b7-3e33-43eb-a9e2-425583b2efa1 GET /v1/drugs/6a1263b7-3e33-43eb-a9e2-425583b2efa1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Deanxit 10 mg - 0.5 mg",
"name_fr": "Deanxit 10 mg - 0.5 mg",
"name_nl": "Deanxit 10 mg - 0.5 mg",
"amp_code": "SAM661596-00",
"strengths": [
"10.0000",
"10.0000",
"0.5000",
"0.5000"
],
"pack_count": 1,
"substances": [
"Melitracen Hydrochloride",
"Melitracen",
"Flupentixol Dihydrochloride",
"Flupentixol",
"Lactose Monohydrate",
"Vegetable Oil, Hydrogenated",
"Betadex"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Melitracen and Psycholeptics",
"authorisation_numbers": [
"1637PI0656F003"
]
}See everything about melitracen und psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.